Published in Nature on September 05, 1996
Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 5.65
Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med (1997) 3.53
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med (2001) 3.47
Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med (2009) 3.38
Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med (2004) 3.30
Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol (2008) 2.79
Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci U S A (2008) 2.24
Mechanisms maintaining peripheral tolerance. Nat Immunol (2009) 2.14
How many thymocytes audition for selection? J Exp Med (1997) 1.90
Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J Exp Med (2008) 1.86
Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood (2004) 1.69
A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med (1997) 1.67
Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med (1997) 1.64
Distinct temporal patterns of T cell receptor signaling during positive versus negative selection in situ. Sci Signal (2013) 1.63
MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J Exp Med (2013) 1.57
Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci U S A (2011) 1.54
Murine thymic selection quantified using a unique method to capture deleted T cells. Proc Natl Acad Sci U S A (2013) 1.52
Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol (2010) 1.51
RelB regulation of chemokine expression modulates local inflammation. Am J Pathol (1997) 1.50
Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med (2000) 1.41
Specific expression of lacZ and cre recombinase in fetal thymic epithelial cells by multiplex gene targeting at the Foxn1 locus. BMC Dev Biol (2007) 1.41
Control of central and peripheral tolerance by Aire. Immunol Rev (2011) 1.37
TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol (2009) 1.33
p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med (1997) 1.32
A role for Fas in negative selection of thymocytes in vivo. J Exp Med (1998) 1.30
Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc (2009) 1.30
Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol (2012) 1.28
Regeneration of the aged thymus by a single transcription factor. Development (2014) 1.23
Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. J Immunol (2010) 1.18
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med (2000) 1.17
HD mice: a novel mouse mutant with a specific defect in the generation of CD4(+) T cells. Proc Natl Acad Sci U S A (1998) 1.16
A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol (2010) 1.14
Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection. J Immunol (2007) 1.13
Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance. J Exp Med (2014) 1.08
Retracted The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J Exp Med (2011) 1.01
Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J Virol (1997) 1.01
DKK1 mediated inhibition of Wnt signaling in postnatal mice leads to loss of TEC progenitors and thymic degeneration. PLoS One (2010) 0.99
Central tolerance: what have we learned from mice? Semin Immunopathol (2008) 0.97
Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol (2014) 0.97
Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther (2009) 0.95
The immunopathology of thymic GVHD. Semin Immunopathol (2008) 0.94
MHC drives TCR repertoire shaping, but not maturation, in recent thymic emigrants. J Immunol (2009) 0.94
FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program. Front Immunol (2013) 0.94
How to find your way through the thymus: a practical guide for aspiring T cells. Cell Mol Life Sci (2011) 0.94
A T cell receptor-specific blockade of positive selection. J Exp Med (1999) 0.93
Molecular signature of recent thymic selection events on effector and regulatory CD4+ T lymphocytes. J Immunol (2005) 0.93
Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J Clin Invest (2003) 0.92
TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation. PLoS Biol (2008) 0.91
Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro. Clin Exp Immunol (1998) 0.90
Antigen presentation by keratinocytes directs autoimmune skin disease. Proc Natl Acad Sci U S A (2003) 0.89
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol (2006) 0.88
Crossreactive αβ T Cell Receptors Are the Predominant Targets of Thymocyte Negative Selection. Immunity (2015) 0.87
Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter. J Virol (2001) 0.87
Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci U S A (2002) 0.87
Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models. Front Immunol (2013) 0.86
Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nat Commun (2011) 0.86
Costimulatory signals are required for induction of transcription factor Nur77 during negative selection of CD4(+)CD8(+) thymocytes. Proc Natl Acad Sci U S A (1999) 0.85
Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells. Clin Exp Immunol (1999) 0.85
Shaping the repertoire of tumor-infiltrating effector and regulatory T cells. Immunol Rev (2014) 0.85
The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla. J Immunol (2009) 0.84
From pre-DP, post-DP, SP4, and SP8 Thymocyte Cell Counts to a Dynamical Model of Cortical and Medullary Selection. Front Immunol (2014) 0.83
Maturation and emigration of single-positive thymocytes. Clin Dev Immunol (2013) 0.82
Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. J Clin Invest (2001) 0.81
Diversity of T cell repertoire shaped by a single peptide ligand is critically affected by its amino acid residue at a T cell receptor contact. Proc Natl Acad Sci U S A (2000) 0.81
Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold. Proc Natl Acad Sci U S A (2012) 0.81
The Contribution of Chemokines and Migration to the Induction of Central Tolerance in the Thymus. Front Immunol (2015) 0.81
Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes. Proc Natl Acad Sci U S A (2002) 0.81
Regulatory T cells for tolerance therapy: revisiting the concept. Crit Rev Immunol (2011) 0.81
In vivo maintenance of T-lymphocyte unresponsiveness induced by thymic medullary epithelium requires antigen presentation by radioresistant cells. Immunology (2003) 0.81
Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains. Mol Immunol (2008) 0.80
Coevolution of TCR-MHC interactions: conserved MHC tertiary structure is not sufficient for interactions with the TCR. Proc Natl Acad Sci U S A (2005) 0.80
Stage-specific changes in fetal thymocyte proliferation during the CD4-8- to CD4+8+ transition in wild type, Rag1-/-, and Hoxa3,Pax1 mutant mice. BMC Immunol (2002) 0.80
The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation. Arthritis Res Ther (2005) 0.80
TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol (2015) 0.79
Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A (2013) 0.79
Functional development of the T cell receptor for antigen. Prog Mol Biol Transl Sci (2010) 0.79
Dendritic cell-MHC class II and Itk regulate functional development of regulatory innate memory CD4+ T cells in bone marrow transplantation. J Immunol (2014) 0.78
Impaired thymic selection and abnormal antigen-specific T cell responses in Foxn1(Δ/Δ) mutant mice. PLoS One (2010) 0.78
Extremely skewed X-chromosome inactivation is increased in pre-eclampsia. Hum Genet (2006) 0.77
Thymic epithelial requirement for γδ T cell development revealed in the cell ablation transgenic system with TSCOT promoter. Mol Cells (2012) 0.76
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis (2000) 6.06
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med (2002) 4.47
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (1995) 3.99
The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61
Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05
CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol (1996) 3.02
Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01
Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med (1989) 2.91
A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (1990) 2.83
c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med (1998) 2.58
Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57
Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (1992) 2.55
T cell selection in the thymus. Immunol Rev (1988) 2.53
The effect of thymus environment on T cell development and tolerance. Cell (1988) 2.45
RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity (1998) 2.42
Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity (1994) 2.40
Transcriptional regulation of Th1/Th2 polarization. Immunol Today (2000) 2.39
NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity (2001) 2.38
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol Cell Biol (1990) 2.38
A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol (2000) 2.33
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med (1986) 2.29
Mature microglia resemble immature antigen-presenting cells. Glia (1998) 2.28
Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A (1993) 2.18
Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity (1998) 2.16
Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry (1990) 2.13
The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity (1998) 2.13
Identity of cells that imprint H-2-restricted T-cell specificity in the thymus. Nature (1986) 2.11
A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity (1994) 2.09
A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature (1989) 2.06
In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science (1991) 2.02
Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity (1998) 2.00
1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol (1984) 1.97
T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature (1989) 1.95
Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J Exp Med (1996) 1.95
Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91
Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol (1995) 1.89
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core. Nucleic Acids Res (1996) 1.83
Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity (1995) 1.82
Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (1996) 1.82
Targeted correction of a major histocompatibility class II E alpha gene by DNA microinjected into mouse eggs. Proc Natl Acad Sci U S A (1989) 1.77
MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int (1990) 1.77
IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76
Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity (2000) 1.74
General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol (1992) 1.74
Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature (1988) 1.73
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1993) 1.72
Antigen presentation abrogated in cells expressing truncated Ia molecules. J Immunol (1989) 1.71
Production of autoreactive I region-restricted T cell hybridomas. J Exp Med (1982) 1.70
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum (1991) 1.66
Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65
The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med (2000) 1.63
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61
Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci U S A (1999) 1.60
Two subsets of epithelial cells in the thymic medulla. J Exp Med (1992) 1.59
Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol (1999) 1.59
Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med (1985) 1.57
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2007) 1.56
A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J (1994) 1.56
Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature (1988) 1.56
Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy. J Exp Med (1990) 1.54
Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol (1997) 1.53
Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc Natl Acad Sci U S A (1991) 1.52
RelB regulation of chemokine expression modulates local inflammation. Am J Pathol (1997) 1.50
I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature (1982) 1.48
Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol (1990) 1.48
In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med (1998) 1.46
Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol (2000) 1.45
Cryptococcosis in the Northern Territory. Med J Aust (1976) 1.45
Cloning of an interleukin-4 inducible gene from cytotoxic T lymphocytes and its identification as a lipase. Cell (1990) 1.44
A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol Cell Biol (1990) 1.43
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol (1996) 1.43
A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol (2001) 1.43
B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol (1996) 1.43
Differences in DNA sequence specificity among MHC class II X box binding proteins. J Immunol (1989) 1.42
Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust N Z J Med (1993) 1.41
T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med (1981) 1.40
Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40
In situ hybridization studies suggest a role for the basic region-leucine zipper protein hXBP-1 in exocrine gland and skeletal development during mouse embryogenesis. Dev Dyn (1993) 1.39
Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem (1999) 1.39
Antipsychotic blood concentrations: nonstandardization of reference ranges. J Clin Psychopharmacol (1997) 1.39
Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity (1995) 1.38
Tumor antigens are constitutively presented in the draining lymph nodes. J Immunol (1999) 1.38
Complex regulation of class II gene expression: analysis with class II mutant cell lines. J Immunol (1985) 1.36
The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J Immunol (1980) 1.36
Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Immunol Rev (1986) 1.36
Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules. J Exp Med (1983) 1.35
Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int (1991) 1.35